Min Hu
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 9
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Oncology top 5%
- Cancer Cells and Metastasis 6
- Immunology top 10%
- Reproductive System and Pregnancy 7
- Molecular Biology top 10%
- Obstetrics and Gynecology top 5%
- Pregnancy and preeclampsia studies 6
-
- Corneal surgery and disorders 9
-
- Ophthalmology and Visual Impairment Studies 7
- Co-authors
- Emi SeiNicholas E. NavinShanshan BaiKen ChenKornélia PolyákRebecca GelmanStuart J. SchnittHaiyan Chen
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Min Hu
139 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Cancer Research 651
- Oncology 629
- Immunology 424
- Molecular Biology 1.2k
- Obstetrics and Gynecology 108
Countries citing papers authored by Min Hu
This map shows the geographic impact of Min Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Hu more than expected).
Fields of papers citing papers by Min Hu
This network shows the impact of papers produced by Min Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Hu. The network helps show where Min Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 44 | |
| 8 | 2022 | 29 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 0 | |
| 11 | 2019 | 77 | |
| 12 | Study on diagnostic value of Rta-IgG combined with VCA-IgA and EA-IgA EB viral antibodies detection in nasopharyngeal carcinoma in Hunan area | 2019 | 2 |
| 13 | 2018 | 20 | |
| 14 | 2017 | 26 | |
| 15 | 2016 | 0 | |
| 16 | 2015 | 18 | |
| 17 | 2015 | 1 | |
| 18 | 2012 | 148 | |
| 19 | 2008 | 80 | |
| 20 | Regulation of In Situ to Invasive Breast Carcinoma Transition | 2008 | 9 |
About Min Hu
Min Hu is a scholar working on Cancer Research, Obstetrics and Gynecology and Complementary and alternative medicine, having authored 144 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Corneal surgery and disorders (9 papers), Ophthalmology and Visual Impairment Studies (7 papers), Reproductive System and Pregnancy (7 papers), Pregnancy and preeclampsia studies (6 papers), MicroRNA in disease regulation (6 papers), Cancer Cells and Metastasis (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (651 citations), Oncology (629 citations) and Immunology (424 citations). Min Hu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Emi Sei, Nicholas E. Navin, Shanshan Bai, Ken Chen, Kornélia Polyák, Rebecca Gelman, Stuart J. Schnitt, Haiyan Chen, Guillermo Peluffo and Tapsi Kumar.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.